Natural History of Human Papillomavirus From Infection to Neoplasia in Adolescents and Young Women - Effect of Tobacco on Cervical Neoplasia in Young Women

Trial Information

Natural History of Human Papillomavirus From Infection to Neoplasia in Adolescents and Young Women - Effect of Tobacco on Cervical Neoplasia in Young Women

The natural history of HPV is most likely influenced by both innate and adaptive mucosal
immunity. More specifically, we hypothesize that Toll like receptors (TLRs) play an
important role in cervical innate immunity to HPV through secretions of proinflammatory,
chemotactic and anti-viral cytokines. Up-regulated TLR expression will also result in
activation of dendritic cells and T cells that in turn will promote a Thl like response
through secretion of several cytokines and consequently, the induction of a successful cell
mediated immune (CMI) response.

We propose to: 1) examine, in cervical cell samples, the association among TRL expression,
TRL-associated cytokines that mediate innate immunity and clearance of incident HPV
infection; 2) examine, in cervical cell samples, the association among TRL expression,
TRL-associated cytokines that induce and mediate adaptive immunity and HPV clearance; and 3)
examine the association among TLR induced Th-1 responses measured in cervical cell samples,
HPV specific CMI responses detected in peripheral blood (PB) and HPV clearance. Adolescent
and young women who were a) entered into the cohort during the initial 1990-1995 period and
have continued to be followed and b) entered into the cohort during the last recruitment
wave (2000-2005) will be asked to continue followup for an additional five years
(2005-2010). These women will have been well characterized at the time of the initiation of
this study with HPV at their entry visit and 4-month interval sampling for HPV DNA,
cytology, bacterial vaginosis, colpophotographs (assessment of cervical maturation), C.
trachomatis and N. gonorrohea testing, cervical cell cytokines by RT-PCR and PB CMI for HPV
16 positive women. Women will be continued to be characterized for the above at the same
intervals through-out the follow-up. Measures of innate and adaptive immunity by RT PCR
using cervical cells and by Luminex technology have been added to the same 4 month interval
testing as HPV DNA, cytology and other cervical cytokines described. Women positive for HPV
16 will get additional blood for CMI using IFN-y EliSpot technique for detection of anti-E6
and E7 responses. We also examine the natural history of anal HPV in these women. We
acknowledge that this design simplifies the pleiotropic nature of cytokines. However, we
feel that this model reflects plausible mechanisms involved in HPV control and is feasible
to test in our cohort. Information garnered from this type of study will be critical in
developing vaccine strategies and therapies as well as illuminating immune responses
developed in the mucosal epithelium.